CanSino Biologics Inc. (OTCMKTS:CASBF – Get Free Report) saw a large decrease in short interest in the month of October. As of October 15th, there was short interest totaling 11,640 shares, a decrease of 87.3% from the September 30th total of 91,840 shares. Based on an average daily volume of 571 shares, the short-interest ratio is currently 20.4 days.
CanSino Biologics Price Performance
OTCMKTS CASBF opened at C$3.95 on Wednesday. The company has a 50 day simple moving average of C$3.99 and a 200-day simple moving average of C$3.75. CanSino Biologics has a 52-week low of C$2.60 and a 52-week high of C$5.60.
CanSino Biologics Company Profile
CanSino Biologics Inc is a China-based biotechnology company focused on the research, development, manufacturing and commercialization of vaccines. The company develops vaccine technologies intended to address infectious diseases, with activities spanning early-stage research, clinical development, regulatory approval and commercial production.
CanSino’s portfolio includes Convidecia, an adenovirus-based COVID-19 vaccine, and Convidecia Air, an inhaled version designed for respiratory immunization.
See Also
- Five stocks we like better than CanSino Biologics
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Receive News & Ratings for CanSino Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanSino Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
